High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)

NCT02448485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-08-01

No results posted yet for this study

Summary

TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.

Conditions

Interventions

PROCEDURE

Aortic Valve Intervention (surgical or transcatheter)

Surgical or interventional aortic valve implantation

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Wolfgang Dichtl, MD, PhD · Medical University Innsbruck

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448485 on ClinicalTrials.gov